51261
(−)-Catechin
puriss., ≥98.5% (HPLC)
Synonym(s):
(−)-trans-3,3′,4′,5,7-Pentahydroxyflavane, (2S,3R)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C15H14O6
CAS Number:
Molecular Weight:
290.27
EC Number:
242-611-7
UNSPSC Code:
12352200
MDL number:
grade
puriss.
assay
≥98.5% (HPLC)
storage temp.
2-8°C
SMILES string
O[C@@H]1Cc2c(O)cc(O)cc2O[C@H]1c3ccc(O)c(O)c3
InChI
1S/C15H14O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-5,13,15-20H,6H2/t13-,15+/m1/s1
InChI key
PFTAWBLQPZVEMU-HIFRSBDPSA-N
Still not finding the right product?
Explore all of our products under (−)-Catechin
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Woo Duck Seo et al.
Bioorganic & medicinal chemistry letters, 15(24), 5514-5516 (2005-10-06)
Chalcones 1-20, a new class of glycosidase inhibitors, were synthesized, and their glycosidase inhibitory activities were investigated. Non-aminochalcones 1-12 had no inhibitory activity, however, aminochalcones 13-20 had strong glycosidase (alpha-glucosidase, alpha-amylase, and beta-amylase) inhibitory activities. In particular, sulfonamide chalcones 17-20
Koneni V Sashidhara et al.
European journal of medicinal chemistry, 50, 230-235 (2012-02-22)
Bioassay guided fractionation of ethanolic extract of the leaves of Bauhinia racemosa led to the isolation of galactolipid and catechin class of the compounds (1-7) from the most active n-butanol fraction (F4). Among the active galactolipids, 1 emerged as the
Eui Seok Shin et al.
Bioorganic & medicinal chemistry, 16(7), 3580-3586 (2008-03-04)
Recent studies have shown that glucose-6-phosphate dehydrogenase (G6PD) is an effectual therapeutic target for metabolic disorders, including obesity and diabetes. In this study, we used in silico and conventional screening approaches to identify putative inhibitors of G6PD and found that